INBRAIN Neuroelectronics, a Graphene Flagship spin-off, has developed an intelligent graphene-based neural implant for personalised neurological therapy in brain disorders.
INBRAIN Neuroelectronics’ work lies at...
Drs Kei Kanie and Ryuji Kato from Nagoya University are trying to break open the data-driven cell culture process development concept to ensure that the future of cell manufacturing will promise quality cell therapy products.
Interview with Dr Axel Gräwingholt, Clinical Co-Chair of the Guidelines Development Group (GDG) at the European Commission Initiative on Breast Cancer and AI
EIT Digital CEO, Willem Jonker, spoke to Clifford Holt, International Editor at The Innovation Platform, about the issues of digital sovereignty and Artificial Intelligence,...
Researchers from Purdue University, USA, have combined machine learning and tandem mass spectrometry to improve the flow of information in drug development.
Tandem mass spectrometry...